Description
Retatrutide + Cagrilintide Blend is an advanced multi-pathway metabolic research blend for laboratory research involving triple incretin receptor agonism and amylin signaling
Blend Category
Advanced Metabolic Research Blend
Research Goals & Applications
- Triple incretin receptor pathway research (GLP-1, GIP, glucagon)
- Multi-receptor metabolic signaling laboratory models
- Amylin and incretin co-pathway investigation
- Advanced metabolic mechanism research studies
- Complex receptor agonism pathway analysis
Components Included
| Compound | Role |
|---|---|
| Retatrutide | Triple incretin receptor agonist (GLP-1/GIP/glucagon) — advanced metabolic research |
| Cagrilintide | Long-acting amylin analog — amylin-pathway signaling research |
Specifications
- Blend Type: Advanced Dual-Compound Research Blend
- Format: Lyophilized powder
- Storage: -20°C recommended, protected from light
- Purity: ≥98% per HPLC (individual components)
- Documentation: COA, HPLC report, batch record
- Usage: Research use only — not for human consumption
Quality & Documentation
- Certificate of Analysis (COA) included with every order
- Third-party HPLC and mass spectrometry testing on every production batch
- Batch-specific traceability documentation from synthesis to shipment
- Reconstitution guide and storage instructions included
- Research library access provided with purchase
For research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. For laboratory research applications only.
Frequently Asked Questions
What is the Retatrutide + Cagrilintide Blend used for in laboratory research?
The Retatrutide + Cagrilintide Blend is an advanced dual-compound metabolic research blend for laboratory investigation involving triple incretin receptor agonism (GLP-1, GIP, and glucagon – via Retatrutide) and amylin-pathway signaling (Cagrilintide) in a single pre-formulated vial. COA-verified. Research use only.
What makes this blend mechanistically distinct?
This is the most mechanistically complex dual-compound metabolic blend in the OligoPoly Labs catalog. Retatrutide simultaneously activates three receptors (GLP-1, GIP, glucagon), while Cagrilintide adds amylin receptor pathway signaling – providing four-receptor coverage in a single pre-formulated research compound. This combination is studied in advanced multi-receptor metabolic pathway research designs.
What purity and documentation standards apply?
Both compounds HPLC-tested at >=98% purity (lot-specific), LC-MS identity verified. Single lot-specific COA covering both compounds.
What assay design considerations apply to this blend?
Cell lines used with this blend must express GLP-1, GIP, glucagon, and amylin receptors. Dose normalization should account for each compound's receptor affinity profile independently. The glucagon receptor component (from Retatrutide) introduces hepatic signaling dimensions that monoagonist and dual-agonist assay designs do not require.
What format does the blend arrive in?
Lyophilized powder, single vial. Reconstitute with bacteriostatic water.
How should it be stored?
Store lyophilized at -20°C. Post-reconstitution: 4°C for up to 30 days or labeled -80°C aliquots.
What related products support advanced metabolic pathway research?
Retatrutide 10mg ($199), Cagrilintide 5mg ($99), Semaglutide + Cagrilintide Blend ($139), GLP-3RT Blend ($249), Metabolic Research Stack ($349), Advanced Multi-Pathway Research Stack ($499).
Is the Retatrutide + Cagrilintide Blend for human use?
No. For laboratory research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. —
Research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Research documentation
Research use FAQ
What documentation is available for Retatrutide + Cagrilintide Blend Research Peptide?
Retatrutide + Cagrilintide Blend Research Peptide includes research-use product information and should be reviewed alongside the certificate of analysis, quality standards, and batch documentation before laboratory use.
How should researchers review storage guidance for Retatrutide + Cagrilintide Blend Research Peptide?
Researchers should review the product page together with the peptide storage guide for handling expectations, lyophilized material considerations, and documentation practices.
Where can the COA for Retatrutide + Cagrilintide Blend Research Peptide be verified?
COA verification is available through the OligoPoly COA resource, which explains certificate review, identity documentation, and quality-control context.
Is Retatrutide + Cagrilintide Blend Research Peptide intended for human use?
No. OligoPoly products are supplied for laboratory research use only and are not intended for human consumption, clinical use, veterinary use, or diagnostic use.
What quality standards apply to Retatrutide + Cagrilintide Blend Research Peptide?
Researchers should review OligoPoly quality standards, purity documentation, and supporting research-library resources before adding any peptide to a laboratory workflow.
Satisfaction guarantee
OligoPoly Labs wants every research order to arrive accurate, intact, and aligned with the listed documentation. If something is wrong with your order, contact support so the issue can be reviewed under our return and refund policy.
